Hurter; Patricia

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hurter; Patricia.The latest application filed is for "solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide".

Company Profile

6.9.21

Hurter; Patricia - Harvard MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 11,291,662 - Hurter , et al. April 5, 2	2022-04-05
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20210251978 - Hurter; Patricia ; et al.	2021-08-19
Pharmaceutical Composition And Administrations Thereof App 20210023070 - Rowe; William ; et al.	2021-01-28
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20200352930 - Hurter; Patricia ; et al.	2020-11-12
Pharmaceutical composition and administrations thereof Grant 10,646,481 - Rowe , et al.	2020-05-12
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 10,537,565 - Hurter , et al. Ja	2020-01-21
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20190070162 - Hurter; Patricia ; et al.	2019-03-07
Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-- 3-carboxamide Grant 9,931,334 - Hurter , et al. April 3, 2	2018-04-03
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20170231970 - Hurter; Patricia ; et al.	2017-08-17
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 9,670,163 - Hurter , et al. June 6, 2	2017-06-06
Pharmaceutical Composition And Administrations Thereof App 20170087144 - ROWE; WIlliam ; et al.	2017-03-30
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20160229806 - Hurter; Patricia ; et al.	2016-08-11
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 9,139,530 - Hurter , et al. September 22, 2	2015-09-22
Pharmaceutical Composition and Administrations Thereof App 20140315948 - Rowe; William ; et al.	2014-10-23
Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20140242172 - Hurter; Patricia ; et al.	2014-08-28
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 8,754,224 - Hurter , et al. June 17, 2	2014-06-17
Pharmaceutical Composition and Administrations Thereof App 20140112988 - Rowe; William ; et al.	2014-04-24
Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20130317060 - Hurter; Patricia ; et al.	2013-11-28
Pharmaceutical Compositions App 20130274180 - Cui; Yong ; et al.	2013-10-17
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 8,410,274 - Hurter , et al. April 2, 2	2013-04-02
Pharmaceutical Composition and Administrations Thereof App 20120258983 - Rowe; William ; et al.	2012-10-11
Pharmaceutical Composition And Administrations Thereof App 20120220625 - Rowe; William ; et al.	2012-08-30
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20120214841 - Hurter; Patricia ; et al.	2012-08-23
Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20110064811 - Hurter; Patricia ; et al.	2011-03-17
Controlled Release Formulations App 20110021598 - Kadiyala; Irina Nikolaevna ; et al.	2011-01-27
Pharmaceutical Composition And Administrations Thereof App 20100256184 - Rowe; William ; et al.	2010-10-07
Pharmaceutical composition and administration thereof App 20100074949 - Rowe; William ; et al.	2010-03-25
Controlled release formulations App 20080070972 - Kadiyala; Irina Nikolaevna ; et al.	2008-03-20
Pharmaceutical compositions App 20060089385 - Cui; Yong ; et al.	2006-04-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.